Corrigendum to: “Re: The Efficacy and Safety of Degarelix: A 12-Month, Comparative, Randomized, Open-Label, Parallel-Group Phase III Study in Patients with Prostate Cancer” by Dieter Jocham and Christian Doehn [Eur Urol 2009;55:1488–9]

✍ Scribed by Bo-Eric Persson

• Book ID: 113611490
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 47 KB
• Volume: 56
• Category: Article
• ISSN: 0302-2838
• DOI: 10.1016/j.eururo.2009.05.023